Olfactory dysfunction in Parkinson's disease Atsushi TakedaAkio KikuchiYasuto Itoyama OriginalPaper Pages: IV2 - IV7
Transcranial sonography of the substantia nigra in patients with Parkinson's disease Hideto MiwaMasae OkawaTomoyoshi Kondo OriginalPaper Pages: IV15 - IV20
Decreased cardiac uptake of MIBG is a potential biomarker for the presence of Lewy bodies Satoshi OrimoTakeshi AminoHitoshi Takahashi OriginalPaper Pages: IV21 - IV28
Drug-drug interactions with levodopa modulating treatment responses in Parkinson's disease Walter E. Haefeli OriginalPaper Pages: IV29 - IV36
Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease Ariel GordinDavid J. Brooks OriginalPaper Pages: IV37 - IV48
Social cognitive impairment in Parkinson's disease Mitsuru KawamuraShinichi Koyama OriginalPaper Pages: IV49 - IV53
Dopamine agonists and valvular heart disease in Japanese patients with Parkinson's disease Masahiro NagaiNoriko NishikawaMasahiro Nomoto OriginalPaper Pages: IV54 - IV57